Table 1.
Comparison of baPWV and baseline characteristics between patients with and without AF
| Characteristics | Patients with AF (n = 166) | Patients without AF (n = 1336) | P |
|---|---|---|---|
| baPWV (cm/s) | 1940 ± 526 | 1731 ± 438 | <0.001 |
| Age (yr) | 69 ± 10 | 61 ± 14 | <0.001 |
| Female gender (%) | 33 | 44 | 0.008 |
| HR (min-1) | 85 ± 18 | 70 ± 13 | <0.001 |
| SBP (mmHg) | 132 ± 17 | 136 ± 21 | 0.031 |
| DBP (mmHg) | 75 ± 11 | 77 ± 12 | 0.010 |
| BMI (kg/m2) | 26.2 ± 4.2 | 26.1 ± 4.0 | 0.706 |
| Diabetes mellitus (%) | 30 | 29 | 0.681 |
| Hypertension (%) | 60 | 69 | 0.025 |
| CVA (%) | 17 | 6 | <0.001 |
| CHF (%) | 30 | 9 | <0.001 |
| Smoking (%) | 15 | 15 | 1.000 |
| Total cholesterol (mg/dL) | 177 ± 37 | 191 ± 44 | <0.001 |
| Triglyceride (mg/dL) | 122 ± 72 | 155 ± 150 | 0.016 |
| eGFR (mL/min/1.73 m2) | 58 ± 18 | 57 ± 21 | 0.544 |
| Medications | |||
| ACEIs and/or ARBs (%) | 61 | 54 | 0.039 |
| β blockers (%) | 47 | 40 | 0.075 |
| CCBs (%) | 33 | 35 | 0.569 |
| Diuretics (%) | 42 | 28 | <0.001 |
baPWV: brachial-ankle pulse wave velocity; AF: atrial fibrillation; HR: heart rate; SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; CVA: cerebrovascular accident; CHF: chronic heart failure; eGFR: estimated glomerular filtration rate; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor blocker; CCB: calcium channel blocker